secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001493152-24-032692
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health receives Nasdaq delisting notice for equity shortfall; provides 2024 revenue guidance of $7.5-9.5M
--------------------------------------------------------------------------------

- Nasdaq notified Syra Health of non-compliance with stockholders' equity minimum of $2.5M (Listing Rule 5550(b)(1)).
- Company has 45 days to submit a compliance plan; Nasdaq may grant up to 180-day extension.
- Full-year 2024 revenue forecast $7.5-9.5M (36%-73% YoY growth), with majority in H2 due to delayed implementation.
- If compliance plan not accepted, stock could be delisted; company can appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224032692/0001493152-24-032692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224032692/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-032692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer